Page last updated: 2024-10-31

metronidazole and B-Cell Chronic Lymphocytic Leukemia

metronidazole has been researched along with B-Cell Chronic Lymphocytic Leukemia in 3 studies

Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Thermos, G1
Tosios, KI1
Weston, AP1
Campbell, DR1
McGregor, DH1
Cherian, R1
Zingman, BS1

Reviews

1 review available for metronidazole and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.
    Digestive diseases and sciences, 1994, Volume: 39, Issue:12

    Topics: Aged; Amoxicillin; Biopsy; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infectio

1994

Other Studies

2 other studies available for metronidazole and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Ibrutinib-associated oral ulcers.
    Oral oncology, 2020, Volume: 100

    Topics: Adenine; Aged; Combined Modality Therapy; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Metr

2020
Fever after cytotoxic therapy of chronic lymphocytic leukemia.
    Cancer investigation, 1999, Volume: 17, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Aztreonam; Candidiasis; Female;

1999